Cargando…

What Is New in the Management of High-Risk Localized Prostate Cancer?

Detalles Bibliográficos
Autores principales:	Wani, Mudassir, Madaan, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861165/ https://www.ncbi.nlm.nih.gov/pubmed/36675384 http://dx.doi.org/10.3390/jcm12020455

Ejemplares similares

Comparison of Outcomes of Active Surveillance in Intermediate-Risk Versus Low-Risk Localised Prostate Cancer Patients: A Systematic Review and Meta-Analysis
por: Mukherjee, Subhabrata, et al.
Publicado: (2023)

Urological Implications Associated with the Use of Recreational Drugs: A Narrative Review
por: Wani, Mudassir, et al.
Publicado: (2022)

Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials
por: Wani, Mudassir M., et al.
Publicado: (2022)

Editorial for the Special Issue on High-Risk Localized and Locally Advanced Prostate Cancer
por: Izumi, Kouji
Publicado: (2023)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)

Clinical risk predictors for differentiated thyroid cancer management: what is new?
Publicado: (2019)

Management of High-Risk Localized Prostate Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2012)

Venous Thromboembolism (VTE) in Post-Prostatectomy Patients: Systematic Review and Meta-Analysis
por: Wani, Mudassir, et al.
Publicado: (2023)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
por: Mukherjee, Subhabrata, et al.
Publicado: (2021)

Optimizing the Management of High-Risk, Localized Prostate Cancer
por: Sundi, Debasish, et al.
Publicado: (2012)

What Is the Correct Name for the New Local Anæsthetic
Publicado: (1885)

Prostate cancer: what is the right message?
por: Glina, Sidney, et al.
Publicado: (2015)

Screening for prostate cancer: Controversy? What controversy?
por: Ablin, R.J., et al.
Publicado: (2009)

What Matters the Most for Hormonal Therapy in West Syndrome: Drug, Dosage, or Duration?
por: Sahu, Jitendra Kumar, et al.
Publicado: (2021)

PIVOT and the challenges of localized prostate cancer care
por: Weinberg, Aviva E., et al.
Publicado: (2012)

What's New in Critical Illness and Injury Science? Estrogen: Is it a new therapeutic paradigm for trauma-hemorrhagic shock?
por: Bhoi, Sanjeev, et al.
Publicado: (2016)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Motoric cognitive risk syndrome: what’s new?
por: Beauchet, Olivier, et al.
Publicado: (2021)

What Should Be Considered for Local Excision in Early Rectal Cancer?
por: Ahn, Taesung
Publicado: (2019)

What's New in Emergencies, Trauma, and Shock: Helicopter Emergency Medical Service in Trauma – Triage Versus Speed
por: Chauhan, Vivek, et al.
Publicado: (2022)

The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery
por: Hughes, Thomas, et al.
Publicado: (2023)

What's New in Critical Illness and Injury Science? Coagulants for local application in the surgical armamentarium!
por: Sharma, Shilpa
Publicado: (2016)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

New targets for resistant prostate cancer
por: Thompson, Timothy C., et al.
Publicado: (2014)

What's New in Emergencies, Trauma and Shock? Mapping and managing missile injuries
por: Abu-Zidan, Fikri M
Publicado: (2011)

Parasitology: What's new, what's unusual?
por: Parija, Subhash Chandra
Publicado: (2020)

2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Local Ablation Therapy of Hepatocellular Carcinoma: What’s New?
por: Lee, Min Woo, et al.
Publicado: (2023)

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology
por: Napodano, Giorgio, et al.
Publicado: (2021)

The role of chemotherapy and new targeted agents in the management of primary prostate cancer
por: Kumar, Sanjeev Srinivas, et al.
Publicado: (2016)

Prognostic Factors after Surgery for Salivary Gland Cancer; What Is New, and What Is Next?
por: Camaioni, Angelo, et al.
Publicado: (2022)

Diabetes update: What's new, what's interesting
por: T. Bloomgarden, Zachary
Publicado: (2022)

Whats New in Critical Illness and Injury Science? Airway management: Is this as good as it gets?
por: Joffe, Aaron M
Publicado: (2014)

What's new in critical illness and injury science? State of the art in management of ARDS.
por: Stawicki, Stanislaw P, et al.
Publicado: (2014)

What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers
por: Puxeddu, Efisio, et al.
Publicado: (2020)

Ongoing Debate on the Management of Small Renal Masses: Should They Be Treated Like Low-Risk Prostate Cancers?
por: Hong, Sung Kyu
Publicado: (2013)

Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence
por: Epstein, Jonathan I
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hqslfvincri9g234vitpluituc